Ezetimibe

ezetimibe
Cholesterol Absorption Inhibitor Merck FDA Monitored

Safety Profile Overview

Cholesterol absorption inhibitor often combined with statins. IMPROVE-IT trial demonstrated cardiovascular benefit of combination therapy.

Generic Name
ezetimibe
Brand Names
Zetia
Therapeutic Class
Cholesterol Absorption Inhibitor
Manufacturer
Merck

What Pharma Signal Tracks for Ezetimibe

Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.

Get Ezetimibe Safety Data via API

One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Ezetimibe.

curl "https://api.pharma-signal.com/drug/safety/ezetimibe" \
  -H "X-API-Key: your_key"

# Returns risk score, adverse event counts,
# serious/death rates, recalls, and signals

Related Safety Intelligence

Pharma Signal provides comparative analysis across therapeutic classes. Compare Ezetimibe against other Cholesterol Absorption Inhibitor drugs, or explore the full manufacturer portfolio for Merck.